Clinical Spectrum of Primary Hypomagnesemia with Secondary Hypocalcemia due to TRPM6 Mutation
Hormone Research in Paediatrics · 25.08.2025 · 1-6
DOI: 10.1159/000547303 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hormone Research in Paediatrics, online erschienen am 25.08.2025. Verfasst von Sommayya Aftab und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology and Diabetes, The Children's Hospital, University of Child Health Sciences, Lahore, Pakistan, sommayya_aftab@ya…. Hauptthemen laut MEDLINE: TRPM Cation Channels, Hypocalcemia, Mutation, Magnesium Deficiency. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Introduction
Hypomagnesemia type 1 (HOMG1) is a rare autosomal recessive condition due to TRPM6 gene mutation, leading to primarily impaired intestinal magnesium absorption resulting in secondary hypocalcemia. This study aimed to determine the clinical spectrum of hypomagnesemia with secondary hypocalcemia due to TRPM6 mutation.
Methods
Retrospective study carried out for a period of 2 years at the Department of Pediatric Endocrinology and Diabetes, University of Child Health Sciences, The Children’s Hospital, Lahore. All genetically confirmed cases of primary hypomagnesemia due to TRPM6 mutation were clinically and biochemically reviewed to look at their clinical spectrum.
Results
Eleven patients (n = 7 male) with homozygous TRPM6 mutation (7 novel variants) from ten different families were reported. Six cases (5 families) had a history of sibling death due to hypocalcemia seizures. Irritability and excessive crying were the first symptoms (mean age = 20 days) followed by intractable seizures (mean age = 2.07 months) in our cohort. Eight patients presented to tertiary care hospital under 6 months of age, 2 between 6 and 12 months, and 1 at 3 years of age. Initial biochemical profile in all cases revealed low magnesium, low calcium, normal/high phosphate, normal alkaline phosphatase, low/normal parathyroid hormone, normal/high 25-OH D level, and low fractional excretion of Mg. All were started on daily oral magnesium with the aim of achieving a normal biochemical profile including magnesium level. All cases are currently maintaining their bone profile on oral magnesium and are seizure free.
Conclusion
HOMG1 due to TRPM6 mutation is a rare condition. We are reporting 11 cases of TRPM6 mutation due to 9 different variants (7 novel). Persistent severe secondary hypocalcemia is a prominent clinical feature of TRPM6 mutation, which can be life-threatening if not treated promptly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Endocrinology and Diabetes, The Children's Hospital, University of Child Health Sciences, Lahore, Pakistan, sommayya_aftab@yahoo.com.
- Department of Pediatric Gastroenterology and Hepatology, The Children's Hospital, University of Child Health Sciences, Lahore, Pakistan.
- Department of Pediatric Endocrinology and Diabetes, The Children's Hospital, University of Child Health Sciences, Lahore, Pakistan.
Zitieren
APA
Aftab, S., Anjum, M. N., Aslam, N., Hussain, S. S., Arshad, K., Saeed, A., & Cheema, H. A. (2025). Clinical Spectrum of Primary Hypomagnesemia with Secondary Hypocalcemia due to TRPM6 Mutation. Hormone Research in Paediatrics, 1-6. https://doi.org/10.1159/000547303
Vancouver
Aftab S, Anjum MN, Aslam N, Hussain SS, Arshad K, Saeed A, et al. Clinical Spectrum of Primary Hypomagnesemia with Secondary Hypocalcemia due to TRPM6 Mutation. Hormone Research in Paediatrics. 2025:1-6. doi:10.1159/000547303
BibTeX
@article{Aftab2025,
author = {Aftab, Sommayya and Anjum, Muhammad Nadeem and Aslam, Nida and Hussain, Syed Saddam and Arshad, Kashan and Saeed, Anjum and Cheema, Huma Arshad},
title = {Clinical Spectrum of Primary Hypomagnesemia with Secondary Hypocalcemia due to TRPM6 Mutation},
journal = {Hormone Research in Paediatrics},
year = {2025},
pages = {1--6},
doi = {10.1159/000547303}
}
EUVIMED